G1 Therapeutics to Present at Investor Conferences in March 2020

NEXT STORY
Enochian Biosciences Announces FDA INTERACT Meeting for a Potential Cure for HIV
PREV STORY
ASLAN Pharmaceuticals to Present at 9th Annual SVB Leerink Global Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sanofi: FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic ...

author_avatar
NASDAQ Market News

Innovation Pharmaceuticals Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Package Brilacidin for Oral Mucositis in Sachet Form

BEVERLY, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...

author_avatar
NASDAQ Market News

Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences

author_avatar
NASDAQ Market News